Full Text View
Tabular View
No Study Results Posted
Related Studies
Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft Vs. Host Disease (COMPLETED)
This study has been completed.
Study NCT00034645   Information provided by Schering-Plough
First Received: May 1, 2002   Last Updated: May 31, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mycoses
Interventions listed in this trial
Posaconazole oral suspension
Additional drug interventions recognized in this trial
Posaconazole
More general drug interventions related to this trial
Anti-Infective Agents
Antibiotics, Antifungal
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Trypanocidal Agents
Sponsors listed in this trial
Schering-Plough


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services